Sponsor pipeline

Institute of Hematology & Blood Diseases Hospital, China clinical trial pipeline

Get alerts when Institute of Hematology & Blood Diseases Hospital, China's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

9 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 8 with minor changes only.

Show 8 trials with minor changes only
  1. Minor
    8 trials marked Unknown by the registry's verification sweep
    7. Minor

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Institute of Hematology & Blood Diseases Hospital, ChinaNot applicable NCT06758726 Registry history

      Changed

    8. Minor

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Institute of Hematology & Blood Diseases Hospital, ChinaNot applicable NCT06658938 Registry history

      Changed

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-30 NCT07850362 Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the Treatment of… Completed
2026-09-30 NCT07850375 Nutritional Intervention for Patients Undergoing Allogeneic Hematopoietic Stem Cell… Not Yet Recruiting
2026-09-25 NCT07840976 Immunotargeted Therapy Plus Low-Dose Chemotherapy in Newly Diagnosed Adult Ph+ B-ALL Phase 2 Not Yet Recruiting
2026-09-23 NCT07836127 Human Albumin Combined With Plasma Exchange for Frailty Intervention Not Yet Recruiting
2026-09-21 NCT07830485 CM336 Plus Daratumumab and Lenalidomide in Transplant-Ineligible Newly Diagnosed Multiple… Phase 2 Not Yet Recruiting
2026-09-21 NCT07831395 Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome… Phase 2 Not Yet Recruiting

Active trials by phase

Early Phase 1
18
Phase 1
35
Phase 1/2
26
Phase 2
102
Phase 2/3
5
Phase 3
11
Phase 4
5
Not charted: 72 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 20

Leukemia (91) · Acute Myeloid Leukemia (AML) (42) · Multiple Myeloma (38) · Acute Lymphoblastic Leukemia (ALL) (33) · Non-Hodgkin Lymphoma (30) · Hemophilia (14) · DLBCL (7) · Myelodysplastic Syndromes (MDS) (5) · Chronic Lymphocytic Leukemia (CLL) (4) · Follicular Lymphoma (4)

Get alerts when Institute of Hematology & Blood Diseases Hospital, China's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free